Financial News
Latest News about REGN
Recent news which mentions REGN
Why Regeneron Wasn't a Healthy Stock Today
June 02, 2022
From Motley Fool
Markets Rise Amid Strength In Tech, Software
June 02, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule
May 20, 2022
From Benzinga
From Benzinga
Tickers
REGN
From Motley Fool
From Benzinga
From Benzinga
From MarketWatch
From Benzinga
If You Invested $100 In Regeneron Pharmaceuticals 10 Years Ago, Here's How Much You Would Have Today
April 21, 2022
Tickers
REGN
From Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
From Motley Fool
54 Biggest Movers From Yesterday
April 20, 2022
From Benzinga
From Motley Fool
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.